Massachusetts Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease – Medical Xpress
Medical Xpress |
Massachusetts Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease
Medical Xpress The treatment, commercially identified as Luxturna, was developed by Spark Therapeutics and approved in December by the Food and Drug Administration (FDA) for patients aged 12 months and older. Luxturna has been shown to improve visual function in … Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease |
